Tumour necrosis factor alpha and its soluble receptors in juvenile chronic arthritis

Rheumatology

Volumn 39, Issue 4, 2000, Pages 432-438

  Rooney, M ^a   Varsani, H ^a   Martin, K ^a   Lombard, P R ^b   Dayer, J M ^b   Woo, P ^a,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY HOSPITAL   (Switzerland)

^c Windeyer Institute of Medical Sciences   (United Kingdom)

Author keywords

Cytokines; Juvenile chronic arthritis; Soluble TNF receptors; Synovial fluid; Tumour necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; DATA ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MALE; PRIORITY JOURNAL; SERUM; SPONDYLOARTHROPATHY; SYNOVIAL FLUID; TISSUE LEVEL;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; SYNOVIAL FLUID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034102885     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Wood PHN. Nomenclature and classification of arthritis in children. In: Munthe E, ed. The care of rheumatic children. Basel: EULAR, 1978:47.
2. Resnick P, Niwayara G. Juvenile chronic arthritis. In: Resnick P, ed. Bone and joint imaging. Philadelphia: WB Saunders. 1989:288-9.
3. Martel W, Holt JF, Cassidy JT. Roentgenologic manifestations of juvenile rheumatoid arthritis. Am J Roentgenol 1962;88:400-23.
4. Cassidy JT, Martel W. Juvenile rheumatoid arthritis: clinicoradiologic correlations. Arthritis Rheum 1977;20(Suppl. 2):207-11.
5. Lang BA, Schneider R, Reilly BJ et al. Radiologic features of systemic onset juvenile rheumatoid arthritis. J Rheumatol 1995;22:168-73.
6. Ball J. Enthesopathy of rheumatoid and ankylosing spondylitis. Ann Rheum Dis 1971;30:213-23.
7. Bywaters EGL. Pathology of the spondyloarthropathies. In: Colin A, ed. Spondyloarthropathies. Orlando, FL: Grove & Strather, 1984:43-68.
8. Will R, Palmer R, Bhalla AK et al. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet 1989;ii:1483-5.
9. Dayer J-M, Arend WP. Cytokines and growth factors. In: Kelly WN, Harris ED, Ruddy S et al. eds. Textbook of rheumatology, 5th ed. Philadelphia: WB Saunders Co, 1997:267-86.
10. di Giovine FS, Nuki G, Duff GW. Tumour necrosis factor in synovial exudates. Ann Rheum Dis 1988;47:768-72.
11. Deleuran BW, Chu CQ, Field M et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Implications for local actions of tumor necrosis factor alpha. Arthritis Rheum 1992;35:1170-8.
12. Rooney M, David J, Symmons J et al. Inflammatory cytokine responses in juvenile chronic arthritis. Br J Rheumatol 1995;34:454-60.
13. Dayer J-M, Beutler B, Cerami A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
14. Sherry B, Cerami A. Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses. J Cell Biol 1988;107:1269-77.
15. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
16. Bertolinl DR, Nedwin GE, Bringman TS et al. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986;319:516-8.
17. Torti FM, Dieckmann B, Beutler B et al. A macrophage factor inhibits adipocyte gene expression: an in vitro model of cachexia. Science 1985;229:867-9.
18. Brennan FM, Chantry D, Jackson A et al. Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;ii:244-7.
19. Collins T, Lapierre LA, Fiers W et al. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 1986;83:446-50.
20. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol 1992;10:411-52.
21. Dayer J-M. Regulation of IL-1/TNF, their natural inhibitors, and other cytokines in chronic inflammation. Immunologist 1997;5:192-201.
22. van Roon JA, van Roy JL, Gmelig-Meyling FH et al. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
23. Lacraz S, Nicod LP, Chicheportiche R et al. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995;96:2304-10.
24. Cope AP, Aderka D, Doherty M et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-9.
25. Roux-Lombard P, Punzi L, Hasler F et al. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993;36:485-9.
26. Ikejima T, Okusawa S, van der Meer JW et al. Induction by toxic-shock-syndrome toxin-1 of a circulating tumor necrosis factor-like substance in rabbits and of immuno-reactive tumor necrosis factor and interleukin-1 from human mononuclear cells. J Infect Dis 1988;158:1017-25.
27. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med 1996;334:1717-25.
28. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
29. Hale KK, Smith CG, Baker SL et al. Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptors. Cytokine 1995;7:26-38.
30. Girardin E, Roux-Lombard P, Grau GE et al. Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group. Immunology 1992;76:20-3.
31. van Zee KJ, Kohno T, Fischer E et al. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci USA 1992;89:4845-9.
32. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397-440.
33. Lepore L, Pennesi M, Saletta S et al. Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin Exp Rheumatol 1994;12:561-5.
34. Prieur A-M, Roux-Lombard P, Dayer J-M. Dynamics of fever and the cytokine network in systemic juvenile arthritis. Rev Rhum Engl Ed 1996;63:163-70.
35. Mangge H, Kenzian H, Gallistl S et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211-20.
36. Madson KL, Moore TL, Lawrence JM et al. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J Rheumatol 1994;21:2359-63.
37. Kreuzer KA, Rockstroh JK, Sauerbruch T et al. A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-alpha. J Immunol Methods 1996;195:49-54.
38. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992;90:533-6.
39. Hohmann HP, Remy R, Brockhaus M et al. Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha). J Biol Chem 1989;264: 14927-34.
40. Porteu F, Brockhaus M, Wallach D et al. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TN F) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils. J Biol Chem 1991;266:18846-53.